BRAF and ovarian cancer: It was recently reported that highly invasive ovarian cancer cells are more dependent on glutamine for survival than cells that present low invasion (Yang et al., 2014) and we recently found that BRAF inhibitor resistant melanoma cells are more invasive than sensitive cells (Sanchez‐Laorden et al., 2014).